Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis. | BMC Infect Dis | 2024 | 38166628 | PubTator, text mining | PubMed |
| A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells. | Life Sci Alliance | 2024 | 38073578 | PubTator, text mining | PubMed |
| A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation. | J Exp Med | 2024 | 37962568 | PubTator, text mining | PubMed |
| Novel PI(3)K-p85α/p110δ-ITK-LAT-PLC-γ2 and Fyn-ADAP-Carma1-TAK1 Pathways Define Reverse Signaling via FasL. | Crit Rev Immunol | 2024 | 37947072 | PubTator, text mining | PubMed |
| A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis. | Blood Adv | 2024 | 37939259 | PubTator, text mining | PubMed |
| Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial. | Blood | 2024 | 37824808 | PubTator, text mining | PubMed |
| Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open-Label, Phase 1 Study. | J Clin Pharmacol | 2024 | 37691236 | PubTator, text mining | PubMed |
| Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis. | Haematologica | 2024 | 37470145 | PubTator, text mining | PubMed |
| Identification of IL-2 inducible tyrosine kinase inhibitors by quantum mechanics and ligand based virtual screening approaches. | J Biomol Struct Dyn | 2024 | 37216319 | PubTator, text mining | PubMed |
| Optical sensing and control of T cell signaling pathways. | Front Physiol | 2023 | 38269062 | PubTator, text mining | PubMed |
| Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era. | Pharmaceutics | 2023 | 38258066 | PubTator, text mining | PubMed |
| Covalent Targeting of Splicing in T Cells. | bioRxiv | 2023 | 38187674 | PubTator, text mining | PubMed |
| Efficacy and Safety of Ibrutinib for Chronic Graft-Versus-Host Disease: A Systematic Review. | Asian Pac J Cancer Prev | 2023 | 38156834 | PubTator, text mining | PubMed |
| Long-term Use of Ibrutinib in Japanese Patients with Steroid Dependent/Refractory cGVHD: Final Analysis of Multicenter Study. | Blood Cell Ther | 2023 | 38149026 | PubTator, text mining | PubMed |
| Case Report: CD19 CAR T-cell therapy following autologous stem cell transplantation: a successful treatment for R/R CD20-negative transformed follicular lymphoma with TP53 mutation. | Front Immunol | 2023 | 38143763 | PubTator, text mining | PubMed |
| CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies. | Int J Mol Sci | 2023 | 38139340 | PubTator, text mining | PubMed |
| A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications. | Molecules | 2023 | 38138527 | PubTator, text mining | PubMed |
| Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder. | J Neuroinflammation | 2023 | 38129902 | PubTator, text mining | PubMed |
| Efficacy and safety of Bruton's tyrosine kinase inhibitors in the treatment of pemphigus: A comprehensive literature review and future perspective. | Heliyon | 2023 | 38125430 | PubTator, text mining | PubMed |
| Cross-linking breast tumor transcriptomic states and tissue histology. | Cell Rep Med | 2023 | 38118424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=8